Search Results 371-380 of 18398 for SARS
... SARS-CoV-2 as compared to SOC treatment with placebo. Participation ... Laboratory confirmed SARS-CoV-2 infection. Admitted to hospital for management ...
SARS-CoV-2 emergency use authorization published sensitivity differences do not correlate with positivity rate in a hospital/reference laboratory setting.
Theiler RN, Warring SK, Young MC, Santos J, Branda ME, Quinton RA, Enninga EAL. Association of SARS-CoV-2 Infection during pregnancy with placental weight and ...
AGID and SARS-CoV-2. Mayo Clinic specialists have published the first report of AGID occurring after SARS-CoV-2 infection. A case study in Neurogastroenterology ...
The purpose of this study is to measure SARS-CoV-2 Spike protein antibody titers in a vaccinated cohort. Participation eligibility. Participant eligibility ...
"We could have had a vaccine for SARS (severe acute respiratory syndrome), but none of the vaccine candidates came through phase 1 trials because the cases ...
COVID-19 can sometimes be treated at home. Understand emergency symptoms to watch for, how to protect others if you're ill, how to protect yourself while ...
The purpose of this study is to prospectively clarify the long-term consequences of SARS-CoV-2 infection in the CNS with multi-modal magnetic resonance (MR) ...
SARS-CoV-2 mutations explained featured image. COVID-19. SARS-CoV-2 mutations explained. Sara Tiner. March 4, 2021. COVID-19 pandemic has increased loneliness ...
... SARS-CoV-2). https://www.fda.gov/vaccines-blood-biologics/whole-blood-and-blood-components-convalescent-plasma-high-titer-anti-sars-cov-2-whole-blood-derived.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!